Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, potentially life-threatening disorder caused by acute ischemic infarction or hemorrhage in the pituitary gland. It is most often associated with the presence of a pituitary gland adenoma. Signs and symptoms include headache, vomiting, visual disturbances, and endocrine dysfunction.
Biomarker and diagnostic research for pituitary apoplexy has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for pituitary apoplexy.
153 publications have been identified in PubMed for pituitary apoplexy. Research spans Case Report / Case Series (58%), Review / Meta-Analysis (16%), and Epidemiology / Natural History (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 88 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
25 |
16% |
Disease patterns and progression | 18 | 12% |
Clinical study results | 12 | 8% |
Other research | 5 | 3% |
Laboratory research | 4 | 3% |
Testing and diagnosis research | 1 | 1% |
Kopanos S (2026). [PMID: 42200845](https://pubmed.ncbi.nlm.nih.gov/42200845/). *Reports (MDPI)*. [Case Report / Case Series]
Birtolo MF (2026). [PMID: 41171601](https://pubmed.ncbi.nlm.nih.gov/41171601/). *Journal of endocrinological investigation*. [Review / Meta-Analysis]
Faiza AR (2026). [PMID: 41797747](https://pubmed.ncbi.nlm.nih.gov/41797747/). *Clinical case reports*. [Case Report / Case Series]
Guerrero-Pérez F (2026). [PMID: 41803534](https://pubmed.ncbi.nlm.nih.gov/41803534/). *Endocrine*. [Case Report / Case Series]
Mustafa R (2026). [PMID: 41631909](https://pubmed.ncbi.nlm.nih.gov/41631909/). *Continuum (Minneapolis, Minn.)*. [Review / Meta-Analysis]
Biagetti B (2026). [PMID: 41699778](https://pubmed.ncbi.nlm.nih.gov/41699778/). *European journal of endocrinology*. [Review / Meta-Analysis]
Fujimura M (2026). [PMID: 41767037](https://pubmed.ncbi.nlm.nih.gov/41767037/). *IJU case reports*. [Case Report / Case Series]
Taguchi A (2026). [PMID: 41735703](https://pubmed.ncbi.nlm.nih.gov/41735703/). *Neurosurgical review*. [Case Report / Case Series]
Chen H (2026). [PMID: 41884344](https://pubmed.ncbi.nlm.nih.gov/41884344/). *Front Neurol*. [Review / Meta-Analysis]
Silva AL (2026). [PMID: 41967485](https://pubmed.ncbi.nlm.nih.gov/41967485/). *J Neuroendocrinol*. [Basic Science / Preclinical]
AI-curated news mentioning pituitary apoplexy
Updated Feb 16, 2026
A recent update on the management of pituitary apoplexy highlights advancements in treatment protocols and patient outcomes. This review synthesizes current research findings to improve clinical practices for this rare endocrine condition.